Bandingkan Harga & Kinerja Bank Mega Tbk. (MEGA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Mega Tbk. dan Organon Pharma Indonesia Tbk.: Bank Mega Tbk. diperdagangkan di Rp1.965 (kapitalisasi pasar 45,91 T, volume 24 jam 37,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bank Mega Tbk. jauh lebih besar — sekitar 439,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MEGA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 45,91 T | 104,4 M |
Volume | 37,3 rb | — |
Lot | 373 | — |
Perputaran | 72,12 jt | — |
Harga Rata-rata | 1.933,62 | — |
Nilai Transaksi | 72,12 jt | — |
Harga Ekuilibrium Indikatif | 1.970 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Mega Tbk.
1969 Established under the name PT Bank Karman, with headquarters in Surabaya 1992 Changed the company name to PT Bank Mega, with headquarters in Jakarta. 1996 Change in shareholding to PT PARA Global Investindo (99.99%) and PT PARA Rekan Investama (0.01%), with the management based on professionalism. 1997 To solidify its image, Bank Mega changed its logo so that as a fiduciary financial institutions the Bank will be more easily recognized through its logo. 1998 Made an investment in the area of service in cooperation with PT Service Quality Center Indonesia, a joint venture between Singapore Airlines and Salim Group, to define Bank Mega's mission, vision, strategy, and strategic service intent, along with various training program. Classified in Category “A” with a CAR of 34%-- far exceeding the 4% minimum stipulated by the monetary authorities, ROE of 226%, ROA 14.78% and IRD 11.39%. 1999 Increased capital by Rp 60.5 billion to Rp 225 billion. Total assets at yearend amounted to Rp 2,744.8 billion. Awarded the internationally recognized ISO 9002 certificate by SGS yarsley International for its main branch operations and head office division. Launched Priority Banking to provide individual, corporate, and other high net worth customers with better, more personalized products and services.Formed strategic alliance with Aetna Life, one of the world’s leading insurance companies, to create Mega Proteksi, which was received favorably by customers.On September 30, acquired 99% shares in PT Indovest Securities, which is engaged in fund and asset management including mutual funds.
Selengkapnya di halaman MEGA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
